The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 31 July 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 249K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parolini, S.
Right arrow Articles by Moretta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parolini, S.
Right arrow Articles by Moretta, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/8/337/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 3, August 7, 2000 337-346


Original Article

X-linked Lymphoproliferative Disease: 2B4 Molecules Displaying Inhibitory Rather Than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–infected Cells

Silvia Parolinia, Cristina Bottinob, Michela Falcoc, Raffaella Augugliarob, Silvia Gilianid, Roberta Franceschinid, Hans D. Ochse, Hermann Wolff, Jean-Yves Bonnefoyg, Roberto Biassonib, Lorenzo Morettab,c, Luigi D. Notarangelod, and Alessandro Morettac
a Dipartimento di Scienze Biomediche e Biotecnologie, Università di Brescia, 25123 Brescia, Italy
b Istituto Nazionale per la Ricerca sul Cancro, 16132 Genova, Italy
c Dipartimento di Medicina Sperimentale, Università di Genova, 16132 Genova, Italy
d Istituto di Medicina Molecolare Angelo Nocivelli, Clinica Pediatrica, Università di Brescia, 25123 Brescia, Italy
e Department of Pediatrics, University of Washington, Seattle, Washington 98195-6320
f Department of Immunology, University of Vienna, A-1090 Vienna, Austria
g Centre d'Immunologie Pierre Fabre, F74164 St. Julien-en-Genevois, France

Correspondence to: Alessandro Moretta, Dipartimento di Medicina Sperimentale, Sezione di Istologia, Via G.B. Marsano 10, 16132 Genova, Italy. Tel:39-10-3537868 Fax:39-10-512747 E-mail:alemoret{at}unige.it.

2B4 is a surface molecule involved in activation of the natural killer (NK) cell–mediated cytotoxicity. It binds a protein termed Src homology 2 domain–containing protein (SH2D1A) or signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), which in turn has been proposed to function as a regulator of the 2B4-associated signal transduction pathway. In this study, we analyzed patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr virus (EBV) infections. We show that, in these patients, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis. Other receptors involved in NK cell triggering, including CD16, NKp46, NKp44, and NKp30, displayed a normal functional capability. However, their activating function was inhibited upon engagement of 2B4 molecules. CD48, the natural ligand of 2B4, is highly expressed on the surface of EBV+ B cell lines. Remarkably, NK cells from XLP patients could not kill EBV+ B cell lines. This failure was found to be the consequence of inhibitory signals generated by the interaction between 2B4 and CD48, as the antibody-mediated disruption of the 2B4–CD48 interaction restored lysis of EBV+ target cells lacking human histocompatibility leukocyte antigen (HLA) class I molecules. In the case of autologous or allogeneic (HLA class I+) EBV+ lymphoblastoid cell lines, restoration of lysis was achieved only by the simultaneous disruption of 2B4–CD48 and NK receptor–HLA class I interactions. Molecular analysis revealed that 2B4 molecules isolated from either XLP or normal NK cells were identical. As expected, in XLP-NK cells, 2B4 did not associate with SH2D1A, whereas similar to 2B4 molecules isolated from normal NK cells, it did associate with Src homology 2 domain–containing phosphatase 1.

Key Words: X-linked lymphoproliferative disease, Epstein-Barr virus infection, natural killer cell, natural cytotoxicity receptor, 2B4 molecule


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS